May 2024 Medical News Summary
JAMA Medical News
Development of Vaccines for Human Metanuma Virus and Respiratory Syncytial Virus
This chapter explores Moderna and AstraZeneca's efforts in creating vaccines for Human Metanuma Virus (HMPV) and Respiratory Syncytial Virus (RSV), focusing on the unique challenges and potential clinical impact of addressing HMPV through vaccine development.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
